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Summary
In female mammalian cells, one of the two X chromo-
somes is inactivated to compensate for gene-dose effects,
which would be otherwise doubled compared with that
in male cells. In somatic lineages in mice, the inactive X
chromosome can be of either paternal or maternal ori-
gin, whereas the paternal X chromosome is specifically
inactivated in placental tissue. In human somatic cells,
X inactivation is mainly random, but both random and
preferential paternal X inactivation have been reported
in placental tissue. To shed more light on this issue, we
used PCR to study the methylation status of the poly-
morphic androgen-receptor gene in full-term human fe-
male placentas. The sites investigated are specifically
methylated on the inactive X chromosome. No meth-
ylation was found in microdissected stromal tissue,
whether from placenta or umbilical cord. Of nine pla-
centas for which two closely apposed samples were stud-
ied, X inactivation was preferentially maternal in three,
was preferentially paternal in one, and was heteroge-
neous in the remaining five. Detailed investigation of two
additional placentas demonstrated regions with bal-
anced (1:1 ratio) preferentially maternal and preferen-
tially paternal X inactivation. No differences in ratio
were observed in samples microdissected to separate tro-
phoblast and stromal tissues. We conclude that meth-
ylation of the androgen receptor in human full-term pla-
centa is specific for trophoblastic cells and that the X
chromosome can be of either paternal or maternal
origin.
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Introduction
Normal female mammalian development requires dos-
age compensation for some genes on the X chromosome.
This takes place through X inactivation, also known as
Lyonization (Lyon 1992). In somatic cells of both female
mice and female humans, X inactivation is usually ran-
dom, resulting in about the same number of cells with
the paternal or the maternal X chromosome inactivated
(for review, see Lyon 1992; also see Tan et al. 1993). In
mice, the final pattern of X inactivation is influenced by
genetic and epigenetic factors (for review, see Belmont
1996): including variation at the X-chromosome con-
trolling element (Xce) (Cattanach et al. 1970; for review,
see Migeon 1998). In addition, because X-inactivation
patterns are established in a relatively small number of
progenitor cells, stochastic effects on X inactivation are
to be expected. In extraembryonic tissues of femalemice,
the paternal X chromosome is specifically inactivated
(Takagi and Sasaki 1975; West et al. 1977; Harper et
al. 1982; Tan et al. 1993). In human female placentas,
however, both random and specific paternal X inacti-
vation have been found. Most of these studies are based
on enzyme analyses of individuals informative for a
polymorphism in the glucose-6-phosphate dehydroge-
nase (G6PD) gene, which is expressed only from the
active X chromosome (Disteche 1995). Of six published
investigations, three report preferential inactivation of
the paternal X chromosome (Ropers et al. 1978; Har-
rison andWarburton 1986; Harrison 1989), whereas the
other three report random X inactivation (Migeon and
Do 1979; Migeon et al. 1985; Mohandas et al. 1989).
More recently, PCR-based methods were used to analyze
the methylation status of two HpaII sites in the andro-
gen-receptor gene and, hence, the X-inactivation pattern
in fetal placentas (Goto et al. 1997). A polymorphic
CAG repeat within the amplified fragment allowed dis-
tinction between the parental alleles (Allen et al. 1992).
This study showed methylation (i.e., inactivation) pref-
erentially on the paternal allele in cultured trophoblastic
cells. In contrast, mesodermal cells exhibited either a 1:
1 ratio or complete demethylation. The results of this
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study could have been skewed because of the limited
number of informative cases ( ), as well as by then  2
selection of cells during culture. However, the finding of
either random or completely absence X inactivation in
mesodermal cells of the human placenta is in agreement
with an earlier publication of findings based on G6PD
analysis (Harrison 1989). Moreover, one study based
on G6PD investigations suggested preferential maternal
X inactivation in some fetal placentas (Migeon and Do
1979), although this finding was not specifically
discussed.
To study the pattern of X inactivation in human full-
term placentas in more detail, we investigated the meth-
ylation status of two HpaII sites and two HhaI sites in
the androgen-receptor gene at multiple nonadjacent dis-
tinct sites within a single placenta, in principle as re-
ported before (Goto et al. 1997). Microdissection of fro-
zen tissue sections allowed selective investigation of the
methylation status of both trophoblastic and stromal
cells. We find that methylation of the androgen receptor
is specific for trophoblastic cells. Within a single pla-
centa, distinct patches appear to have inactivated either
the maternal or paternal X chromosome preferentially,
indicating that a heterogeneous pattern of X inactivation
exists in human female placentas.
Material and Methods
Tissue Collection and Processing
Placentas were collected by the Department of Gy-
necology and Obstetrics, Zuiderziekenhuis (Rotterdam),
and were processed directly after delivery at full term.
Only normal placentas resulting from normal pregnancy
and delivery of a healthy child were included in this
study. In all cases, samples of maternal blood from spon-
taneous bleeding during delivery was collected in a hep-
arin-containing tube. The placenta and the umbilical
cord were washed with PBS to remove contaminating
maternal blood, and an incision was made at the site of
constriction to remove fetal blood. High-molecular-
weight DNA from maternal blood was isolated accord-
ing to standard procedures (proteinase K–SDS treatment
followed by phenol-chloroform extraction and ethanol
precipitation [Maniatis et al. 1982]). Subsequently, three
fragments of umbilical cord were taken from the site of
constriction and were thoroughly washed three times in
fresh PBS. One sample was fixed in formalin overnight
and was embedded in paraffin, whereas the other two
were snap-frozen in liquid nitrogen and were stored at
80C until being used. Of the twomale and nine female
placentas (cases 1–11), four samples from one region
within one cotyledon were dissected and thoroughly
washed as described above. The samples were each ∼0.5
cm3 in size. One sample was fixed in formalin and em-
bedded in paraffin, and the others were snap-frozen. In
principle, the same protocol was used on two more pla-
centas (cases 12 and 13), with the exception that, instead
of one placenta specimen, nine nonadjacent regions (in-
cluding all cotyledons) were collected, numbered
“1”–“9.” From each site, four samples were collected
and were designated “A1,” “A2,” “B1,” and “B2” (fig.
5A). After the samples were rinsed, they were divided
into two groups; one was fixed in formalin and embed-
ded in paraffin, and the other was snap-frozen. In ad-
dition, the corresponding umbilical cords were sliced
into six fragments of similar size. From these fragments,
two samples were taken, and, after they were rinsed, one
sample was fixed in formalin and embedded in paraffin,
and the other was snap-frozen. Formalin-fixed paraffin-
embedded samples were cut into 4-mm sections and were
stained with hematoxylin and eosin, for histological ex-
amination. In addition, for each frozen sample from
which DNA was isolated, additional 4-mm sections were
made, fixed with acetone, and stained with hematoxylin
and eosin, for histological examination.
Microdissection
Snap-frozen tissue sections were cut by a Reichert-
Jung 2800 Frigocut E cryostat. One 5-mm and three 20-
mm serial sections were cut and placed on an ethanol-
cleaned glass slide. Sections were stained for enzymatic
alkaline phosphatase reactivity as described elsewhere
(Mosselman et al. 1996) and air dried. The 5-mm section
was used for histological examination by light micros-
copy after hematoxylin and eosin staining. The areas of
specific histological interest were selected by means of
an inverted microscope (Axiovert 10; Carl Zeiss) and
were microdissected by a modified Pasteur pipette with
an ultrafine pointed tip. The pipette was prepared by
brief flaming and gentle pulling of glass piping. The mi-
crodissected tissues were immediately placed in a pre-
chilled Eppendorf tube and were dissolved in TNE (10
mM Tris, 400 mM NaCl, 2 mM EDTA, pH 8.2). Pro-
teinase K (10 mg/ml) and SDS (10%) were added, and
the sample was incubated overnight at 37C. DNA was
then extracted with phenol/chloroform /isoamylalcohol
(25:24:1) (Merck) and was precipitated by use of gly-
cogen (10 mg/ml) (Boehringer) as the carrier. Pellets were
dissolved in 10 ml of TE (Tris 10 mM, EDTA 0,1 mM,
pH 8.0). The amount of DNA extracted was estimated
by comparison with a series of DNA samples with
known concentration, on a 1% agarose gel.
Androgen-Receptor Methylation
All experiments were done in duplicate, essentially as
described by Allen et al. (1992). For each DNA sample
from one isolation of the nonmicrodissected samples,
three reactions were done, as follows. Two micrograms
of DNA was digested at 37C overnight, with either 10
U of RsaI alone, 10 U of RsaI and 20 U of HpaII, or
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Figure 1 PCR analysis of X inactivation in two full-term male
(i.e., XY) placentas (cases 1 and 2). One allele was detected in these
samples after RsaI digestion only, confirming the presence of one X
chromosome. Also as expected, two alleles were found in the matched
maternal (i.e., XX) blood samples after RsaI digestion and amplifi-
cation, representing the presence of two X chromosomes. Analysis of
the methylation status of both theHpaII sites and theHhaI sites within
this particular fragment of the androgen-receptor gene showed com-
plete demethylation (i.e., absence of amplification products) in the
placental samples. This confirms that the only X chromosome present
is active. The presence of DNA after digestion with either HpaII or
HhaI in these cases was verified by amplification of an H19-specific
fragment lacking either of these restriction sites (not shown).
10 U of RsaI and 20 U of HhaI, in a total volume of
50 ml of digestion buffer (Pharmacia). The restriction
endonucleases were purchased from Pharmacia LKB Bi-
otechnology. RsaI was used to reduce the size of the
genomic DNA fragments to facilitate HpaII digestion
and HhaI digestion. The samples were then purified by
phenol/chloroform extraction and ethanol precipitation,
and the pellet was dissolved in 10 ml of H2O. The same
protocol was used for the microdissected samples, except
that 50 ng of DNA was digested, and one tenth of the
digested material was subsequently used for amplifica-
tion. 5′ End-labeling of the PCR products was done by
use of 10 pmol of primer AR-a (5′-CCGAGGAGCT-
TTCCAGAATC-3′ [Mutter et al. 1995] with T4-poly-
nucleotide kinase (New England Biolabs) and [g-32P]
ATP (ICN), according to standard procedures. PCR was
conducted in a total volume of 20 ml that contained 1
ml of solubilized DNA (∼150 ng), 1 # Taq DNA poly-
merase buffer with 1.0 mM MgCl2, 0.1 mM of each
dNTP, 25 pmol of primer AR-b (5′-TACGATGGGCTT-
GGGGAGAA-3′), 15 pmol of unlabeled primer AR-a,
10 pmol of end-labeled primer AR-a, and 1 U of Taq
DNA polymerase (Promega). The reactions were done
in a PTC-200 Thermal Cycler (MJ Research), as follows:
denaturation at 94C for 5 min; 28 cycles of denatur-
ation at 94C for 1 min, annealing at 60C for 1 min,
and extension at 7C for 1 min; and a final extension
at 72C for 6 min. Labeled amplified DNA was mixed
with 5 ml of formamide loading dye (95% formamide,
20 mM EDTA, 0.05% bromophenol blue, and 0.05%
xylene cyanol). Four microliters of each sample was de-
natured at 95C for 3 min and were loaded on a 6%
0.4-mm polyacrylamide gel. Electrophoresis was at 60
W for ∼3 h. Kodak BioMax MR-1 film was used for
autoradiography of the gel after the latter was dried.
The ratio between the alleles was analyzed quantitatively
by an Alpha Imager 200 Digital Imaging & Analysis
System (Alpha Innotech). In the absence of a PCR prod-
uct after amplification, control for the presence of DNA
after HpaII digestion or HhaI digestion and purification
was accomplished by amplification of an H19-specific
region (exon 5) of 331 bp without HpaII sites and HhaI
sites, by means of primers HN11 (5′-GCGACTCCATC-
TTCATGGCCAC-3′) and HN12 (5′-GGCCCTGCACA-
GGCACTTGC-3′) (Looijenga et al. 1997; Verkerk et al.
1997).
Results
To verify the usefulness, for our purpose, of methyl-
ation analysis of the androgen receptor, we analyzed two
full-term male placentas (cases 1 and 2). Whereas am-
plification products representing one of the maternal al-
leles were observed in the RsaI-digested DNA samples
isolated from the placenta, no products were found after
digestion with either HpaII or HhaI (see fig. 1). The
presence of DNA in these samples was verified by am-
plification of an H19 gene fragment (not shown) that
lackedHpaII sites andHhaI sites. The results in the male
placentas also demonstrated the absence of contami-
nating maternal blood in the samples studied. Similar
results were obtained in samples of matched umbilical
cords (not shown). To investigate whether stromal cells
lack methylation of the androgen-receptor gene, we per-
formed microdissection of multiple stromal components
of two placentas (a total of nine samples) (see fig. 2A
and B) and matched umbilical cords (a total of three
samples) (not shown). As shown in figure 2C, analysis
of an amount of DNA equivalent to that in ∼850 cells
showed no methylation, although DNA was clearly
present.
We subsequently applied the protocol to tissue sec-
tions of nine full-term female placentas (cases 3–11).
Two closely apposed tissue samples (A and B) within
one cotyledon, the functional unit of placenta, were stud-
ied. The areas from which DNA was isolated were ∼0.5
cm in diameter. The amount of DNA within a single
experiment corresponded to that found in ∼17,000 cells.
Because, for each sample, the percentage of methylation
of HpaII sites and HhaI sites was similar (schematically
illustrated in fig. 3), we will refer only to theHpaII data.
We were able to identify the parental origin of the alleles
in all cases except case 6, which lacked maternal DNA
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Figure 2 Representative example of results of histological anal-
ysis of a frozen tissue section of a human full-term female placenta
(case 9) before (panel A) and after (panel B) microdissection of stromal
(S) and trophoblastic (T) tissue. The trophoblastic cells were identified,
prior to microdissection, by an enzymatic staining for alkaline phos-
phatase reactivity. C, Methylation analysis of microdissected stromal
cells taken from two sites (I and II). All samples (one region from site
I and two regions from site II) showed absence of methylation after
digestion with HpaII, while DNA was present, as demonstrated by
amplification of an H19-specific fragment lacking either of these re-
striction sites. Amplification products of the androgen receptor were
also observed when undigested DNA was studied (not shown). D,
Methylation analysis of microdissected trophoblastic tissue: three
regions from site I and two regions from site II. Note that the ratio
between the maternal (M) and paternal (P) alleles is similar, ∼65:35
for site A and ∼30:70 for site B, as in the original samples (see fig.
4A and text).
Figure 3 Schematic representation of correlation between meth-
ylation status of HpaII recognition sites and HhaI recognition sites,
in the androgen-receptor gene, as determined in the samples included
in this study. Only the percentages found for the upper allele are shown.
Because of the linear relationship between the findings, only the data
of the HpaII analysis are discussed.
of sufficient quality. The upper allele was maternal in
all informative cases, except for case 11, in which it was
paternal. The results of the methylation analysis of the
placentas are shown schematically in figure 4A. The per-
centage of the upper allele found after RsaI digestion
only (50% is expected and represents a 1:1 ratio) is
compared with the percentage of methylation of the up-
per allele after digestion with RsaI and HpaII. In the A
series (see fig. 4A), X inactivation was found in nearly
a 1:1 ratio in case 7, with preferential paternal inacti-
vation in cases 8 and 10, preferential maternal inacti-
vation in cases 4, 5, and 9, and almost completematernal
inactivation in cases 3 and 11. Most (78%) of the results
from the B series (see fig. 4A) were in agreement with
the results from the A series, although two placentas
showed a clear difference. In particular, either paternal
or maternal X inactivation was found in case 3, and
preferentially maternal or preferentially paternal X in-
activation was detected in case 9. Although the parental
origin of case 6 could not be determined, in both samples
the inactive X chromosome was from the same parent.
The results for cases 3, 7, and 11 are shown in figure
4B. The validity of this finding for placental samples is
supported by the balanced pattern of X inactivation
found in matched samples of umbilical cord (see fig. 4A).
Of note is the balanced pattern found in microdissected
regions of smooth muscle and epithelial cells from the
umbilical cord (not shown), explaining the balanced ra-
tio found in umbilical cord as total sample, despite the
absence of methylation in the stromal component (see
above). The lower allele is preferentially detected after
RsaI digestion only, in most umbilical cord samples (me-
dian 45, range 41–50) and all placental samples (median
47, range 43–48). Although this is most likely explained
by amplification selection, the method remains infor-
mative for our purpose. Together, these data suggest
that, at least to a certain extent, X inactivation can be
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Figure 4 A, Schematic representation of comparison between
allelic percentage of methylation of HpaII-sites in umbilical cord sam-
ples (U3–U11) and placental samples (3A–11A and 3B–11B) and of
ratio between alleles after RsaI digestion only. Only the percentages
of the upper allele are indicated. For all cases, with the exception of
cases 6 and 11, the upper allele is of maternal origin. Case 6 was not
informative, because of lack of maternal DNA of appropriate quality,
whereas the upper allele of case 11 was of paternal origin. The A and
B series are shown separately. B, Representative examples of results
with regard to methylation status of HpaII-sites after electrophoresis
and exposure, in the A and B series of cases 3, 7, and 11. Case 3
showed absolute maternal inactivation (i.e., methylation) in the A sam-
ple and absolute paternal inactivation in the B sample, whereas an ∼1:
1 ratio was found for both samples of case 7. Case 11 showed an
almost absolute maternal inactivation in both samples.
heterogeneous within the trophoblast of a single human
full-term placenta.
To study in more detail this phenomenon of hetero-
geneous X inactivation, we investigated two additional
full-term female placentas (cases 12 and 13). Four sam-
ples (A1, A2, B1, and B2) were taken from nine (cases
1–9) distinct regions (including all individual cotyle-
dons). The alleles of the androgen receptor of case 12
could not be separated sufficiently to allow accurate
measurement. In spite of this, a heterogeneous pattern
of X inactivation was found (not shown), varying from
preferential inactivation of the X chromosome from one
parent (maternal DNA of appropriate quality was not
available) to preferential inactivation of the X chro-
mosome derived from the other parent. Six of the nine
sites within this placenta showed such heterogeneity. The
sites from which the samples for analysis of case 13 were
taken are illustrated schematically in figure 5A, the re-
sults are shown schematically in figure 5B, and repre-
sentative examples are illustrated in figure 5C. For case
13, the upper allele was found to be of maternal origin
(see fig. 5C). On average, the four samples taken within
a site are more similar than samples taken from different
sites (see fig. 5B). All four samples taken from each of
six of the nine sites showed a similar pattern of X in-
activation. This varied from an almost balanced pattern
(site 5) to preferentially maternal (sites 3, 4, and 6) to
preferentially paternal (site 8) to almost absolutely pa-
ternal (site 9) X inactivation. A more heterogeneous pat-
tern was found for the other three sites, varying from
almost completely maternal (in one sample from site 1,
although the other samples showed a balanced pattern)
to preferentially paternal (site 2) to balanced (site 7) X
inactivation. These data demonstrate that the inactive
X chromosome in full-term human female placentas can
be of either maternal or paternal origin. Overall, the
pattern of X inactivation seems to be independent of
location, although some clustering might be present
(e.g., at sites 3 and 6 and sites 7–9). Different patterns
were observed in two of the three cotyledons for which
two separate sites were investigated. Again, a ratio of
∼1:1 was detected for the matched umbilical cord sam-
ples tested, of which six per case were studied (see case
13 in fig. 5B and C).
Subsequently, trophoblastic tissue from placentas 7
and 9 was isolated by microdissection of frozen tissue
sections from the samples previously studied (see fig. 2A
and B). The trophoblastic cells were identified prior to
microdissection, by enzymatic staining for alkaline phos-
phatase activity. Placentas 7 and 9 were specifically se-
lected for this purpose because the samples taken from
placenta 7 showed a balanced ratio whereas placenta 9
included one sample with preferential inactivation of the
maternal X chromosome and another sample with pref-
erential inactivation of the paternal X chromosome (see
fig. 4A). All three microdissected samples (all from site
I) from placenta 7 (not shown) and five microdissected
samples (three from site I and two from site II) from
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Figure 5 A, Schematic representation of geography of sites (1–9) from which samples of placenta 13 were taken for analysis. Note that
all cotyledons were included and that four samples per site (A1, A2, B1, and B2) were tested. B, Schematic representation of results of methylation
analysis of HpaII sites in umbilical cord samples (U) and placental samples (1–9) of case 13 (as described in the legend to fig. 4A). Each of the
four samples is denoted only in terms of its site of origin, not in terms of its specific sublocalization. C, Representative examples of results with
regard to methylation analysis of samples of case 13, obtained and represented as described in the legend to figure 4B. Note both the balanced
ratio between the alleles in the umbilical cord samples and the heterogeneity in the different placental samples (e.g., between samples within a
particular site [e.g., 1A2 and 1B2] and between sites [1–3 and 9]).
placenta 9 (see fig. 2D) showed the same ratio as had
been seen in the original sample.
Discussion
To date, the pattern of X inactivation in human full-
term placentas has not been determined, although both
random and preferential inactivation of the paternal X
chromosome have been described. Here we have shown
that human full-term female placentas can exhibit in-
activation of both the paternal and the maternal X chro-
mosome. This reflects the pattern in trophoblastic cells,
because the stromal cells lacked methylation of the an-
drogen receptor, as has been reported by others (Goto
et al. 1997). Our results from the nonmicrodissected
samples are therefore not influenced by the presence of
contaminating stromal tissue. This is supported by the
histological observation that all placental samples in-
cluded in this study showed a similar contribution of
stromal tissue, including those that had either absolute
paternal or absolute maternal X inactivation. In addi-
tion, the possibility that results could be skewed because
of the limited number of clonal cells under investigation
can be disregarded, because the results from the mi-
crodissected samples of DNA (equivalent to the DNA
in ∼850 cells) are similar to those obtained from the
matched total samples of DNA (equivalent to the DNA
in ∼17,000 cells). Moreover, no discrepancies between
the duplicate experiments were observed (not shown).
Our data show that the pattern of X inactivation in the
trophoblastic cells of full-term female placentas is similar
to that found in the fur of tortoiseshell cats, thus dif-
fering from the pattern found in most somatic tissues,
including mouse and human liver (Ricciuti et al. 1976;
Mrozek et al. 1991). This coarser pattern explains the
conflicting results in the literature. The differences be-
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tween samples and sites within a single full-term female
placenta might be explained by clonal expansion of a
limited number of trophoblastic progenitor cells with
either an inactive maternal X chromosome or an inactive
paternal X chromosome. Although this idea has to be
proved by analysis of a large number of samples taken
from an informative placenta, it is in accordance with
the generally accepted view of the trophectoderm for-
mation from a limited number of cells functioning as
progenitors. In fact, the trophectoderm is formed at ap-
proximately day 3 postcoitus in mice and at approxi-
mately day 4 postcoitus in humans; during this period
of development in mice, X inactivation occurs specifi-
cally in the trophectodermal cells (whereas it occurs at
approximately days 5–6 in somatic cells) (Takagi and
Sasaki 1975; Tan et al. 1993). In this model, it is likely
that the timing of X inactivation during development of
female mice and female humans is approximately the
same, except that, in humans, both the paternal X chro-
mosome and the maternal X chromosome can become
inactivated in somatic—as well as in placental—tissues.
It has been suggested that, in mice, the strength of the
Xce allele determines which of the two X chromosomes
present in female cells will be inactivated (Cattanach et
al. 1970), which might result in a skewed pattern of X
inactivation. More recently, a similar phenomenon has
been suggested to occur in humans (Naumova et al.
1998). This process might explain our data found in
full-term placentas, if it is assumed that, in the most
heterogeneous cases (i.e., those which show either sites
with paternal X inactivation only or sites with maternal
X inactivation only) XCE alleles of similar strength are
present. In addition, placentas showing preferential in-
activation of either the paternal or the maternal X chro-
mosome would be the result of the presence of XCE
alleles with different strengths. Although this model is
of interest and deserves to be studied in more detail, it
does not explain why the heterogeneity inX inactivation,
as observed in the present study, is restricted to tropho-
blastic tissue—that is, is not found in the matched sam-
ples of the umbilical cord. This indicates that, if anXCE-
like mechanism does exist, it is likely to be under the
control of tissue-specific factors.
The heterogeneity of X inactivation in human full-
term placentas is consistent with the phenotypic differ-
ences reported between mice with an extra copy of the
X chromosome and humans with an extra copy of the
X chromosome. In the mouse, the presence of an extra
X chromosome of maternal origin results in an almost
complete absence of placental tissue and is incompatible
with normal development (Takagi and Sasaki 1975). Un-
like humans, mice are unable to inactivate the maternal
X chromosome in extraembryonal lineages. In humans,
supernumerary X chromosomes of either maternal or
paternal origin is not lethal but lead to Klinefelter syn-
drome (Jacobs et al. 1988). This difference betweenmice
and humans might be explained by the X-inactivation
pattern that normally occurs in the human placenta, as
has been demonstrated in the present study. Consistent
with this model are the results reported by Plenge et al.
(1997), who recently identified a mutation in the pro-
moter of theXIST gene in families with a skewed pattern
of X inactivation. Female carriers of the mutation were
found to preferentially inactivate the affected chromo-
some in somatic tissue. In all informative cases, this X
chromosome was inherited from the mother. It is likely
that the maternal X chromosome is also preferentially
inactivated in the extraembryonal lineages of individuals
who show no overt phenotype. Recently, however, a
functional difference between the maternal and paternal
human X chromosomes has been suggested (Skuse et al.
1997); consistent differences in social adjustment of
Turner syndrome patients have been linked to the pa-
rental origin of the only X chromosome present. It is
conceivable that the maternal and paternal X chromo-
somes are functionally different but randomly inacti-
vated. Therefore, it would be of interest to study the
human homologue of Esx1, which has been found to
be an X chromosome–imprinted regulator of early
mouse fetal and placental development (Li and Behringer
1998).
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